The same conclusion was corroborated in a subgroup analysis excluding individuals with severe obesity (Supplementary Table S1), indicating that IGFBP2 is unlikely to be a major contributor to the hepatic fibrosis process. Here, IGFBP2 is linked to obesity due to melanocortin 4 receptor deficiency.